Literature DB >> 32399460

Cost Analysis of Biliary Drainage Using Metal versus Plastic Stents in Hepatocellular Carcinoma Patients with Obstructive Jaundice.

Esam Elshimi1, Wesam Morad2.   

Abstract

BACKGROUND: The optimal method of biliary drainage for biliary obstruction caused by hepatocellular carcinoma (HCC) is controversial, and the possible endoscopic application of plastic and metal stents is the least invasive procedure to improve patients' quality of life. AIM: Our objective was to study cost evaluation based on a clinical efficacy of both procedures in a randomized trial comparing both approaches in patients with biliary obstruction caused by HCC.
METHODS: The strategy of management was based on clinical effectiveness of biliary drainage with either metal or plastic stents in 90 patients over a 1-year follow-up period. Total (direct and indirect) costs were evaluated.
RESULTS: The direct costs were EGP 40,857.84 and 21,802.62 per patient with plastic and metal stents, respectively. Concerning the indirect costs, EGP 888 and 454 were spent for each patient with plastic and metal stents, respectively. The differences in the costs resulted from patients with plastic stent insertion requiring more second endoscopic retrograde cholangiopancreatography procedures and more medication, medical consultation, and hospitalization during the year of follow-up.
CONCLUSIONS: Based on this analysis, the use of metal stents rather than plastic stents in biliary drainage is more cost effective for this group of patients.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Endoscopic retrograde cholangiopancreatography; Hepatocellular carcinoma; Metal and plastic stents; Obstructive jaundice

Year:  2019        PMID: 32399460      PMCID: PMC7206597          DOI: 10.1159/000503862

Source DB:  PubMed          Journal:  Gastrointest Tumors        ISSN: 2296-3774


  19 in total

1.  The valuation of productivity costs due to premature mortality: a comparison of the human-capital and friction-cost methods for schizophrenia.

Authors:  R Goeree; B J O'Brien; G Blackhouse; K Agro; P Goering
Journal:  Can J Psychiatry       Date:  1999-06       Impact factor: 4.356

2.  The friction cost method for measuring indirect costs of disease.

Authors:  M A Koopmanschap; F F Rutten; B M van Ineveld; L van Roijen
Journal:  J Health Econ       Date:  1995-06       Impact factor: 3.883

Review 3.  Hepatocellular carcinoma presenting with obstructive jaundice.

Authors:  Eric C H Lai; Wan Yee Lau
Journal:  ANZ J Surg       Date:  2006-07       Impact factor: 1.872

Review 4.  [Malignant biliary obstruction, general review and clinical practice].

Authors:  Didier Bonnel; Thierry André; Benoît Mader; Jean-François Lefebvre; Emmanuel Bensoussan; Claude Liguory
Journal:  Bull Cancer       Date:  2013-05       Impact factor: 1.276

5.  Obstructive jaundice caused by tumor emboli from hepatocellular carcinoma.

Authors:  J Hu; Z Pi; M Y Yu; Y Li; S Xiong
Journal:  Am Surg       Date:  1999-05       Impact factor: 0.688

6.  Surgical intervention for obstructive jaundice due to biliary tumor thrombus in hepatocellular carcinoma.

Authors:  Shu You Peng; Jian Wei Wang; Ying Bin Liu; Xiu Jun Cai; Gui Long Deng; Bin Xu; Hai Jun Li
Journal:  World J Surg       Date:  2003-11-26       Impact factor: 3.352

Review 7.  Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

8.  Hepatectomy for Hepatocellular Carcinoma with Bile Duct Tumor Thrombus, Including Cases with Obstructive Jaundice.

Authors:  Tatsuya Orimo; Toshiya Kamiyama; Hideki Yokoo; Kenji Wakayama; Shingo Shimada; Yosuke Tsuruga; Hirofumi Kamachi; Akinobu Taketomi
Journal:  Ann Surg Oncol       Date:  2016-03-22       Impact factor: 5.344

9.  Hepatocellular carcinoma embolus to the common hepatic duct with no detectable primary hepatic tumor.

Authors:  M J Buckmaster; R W Schwartz; G E Carnahan; W E Strodel
Journal:  Am Surg       Date:  1994-09       Impact factor: 0.688

10.  The efficacy of endoscopic palliation of obstructive jaundice in hepatocellular carcinoma.

Authors:  Semi Park; Jeong Youp Park; Moon Jae Chung; Jae Bock Chung; Seung Woo Park; Kwang-Hyub Han; Si Young Song; Seungmin Bang
Journal:  Yonsei Med J       Date:  2014-09       Impact factor: 2.759

View more
  1 in total

1.  The Evaluation of Clinical Status of Endoscopic Retrograde Cholangiography for the Placement of Metal and Plastic Stents in Cholangiocarcinoma Therapy.

Authors:  Min Gong; Qiang Li; You Xu; Yunhui Fu
Journal:  Comput Math Methods Med       Date:  2022-10-11       Impact factor: 2.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.